Navigation Links
Cough medication to cure fibromyalgia

Cough medication formula called dextromethorphan may be able to help people// suffering from fibromyalgia.

In a research done by scientists of University of Florida the cough medicine seemed to bring relief in the intensity of pain suffered by the people from fibromyalgia.

Fibromyalgia syndrome occurs with extensive musculo-skeletal pain and fatigue. There re no known causes of this diseases. More women than men report to be suffering from fibromyalgia, although the condition can affect anybody and at any age. There is no single therapy that can treat the condition of fibromyalgia.

The new study suggests that there may be an alternate way of treating fibromyalgia. The treatment may not be one single medication but a whole lot of interventions designed to bring total relief to the patients. In this regard the role of dextromethorphan may be quite important.

Scientists however warn the patients of the condition against self-medication or of using the drug without physician’s advice as the dosage and the guidelines for the use of the medication is yet to be established.

The result was published in the recent issue of the Journal of Pain
'"/>




Page: 1

Related medicine news :

1. Cough Syrup Ingredient Linked to Stroke
2. Women Worse Affected By Chronic Cough
3. A Drug That Might Relieve Chronic Cough
4. Studying The Effectiveness Of Cough Syrups
5. Foods Rich In Flavonoids Effective In Prevention Of Cough
6. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
7. Rising Rates of Whooping Cough in Idaho
8. Cough Syrups No More Effective Than Sugar Water
9. Bariatric Surgery: Medicare, Will Now Cough Up For ‘Throwing Weight
10. Zimbabweans Will Need To Cough Up More on Health Costs
11. Many Nonprescription Cough Medicines Proves Ineffective
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... ... Cellairis is a worldwide mobile device and computer repair franchise that is known ... Samsung Galaxy devices with premium parts and accessories. Cellairis has recently set-up for business ... customers. While customers do their shopping, Cellairis can accomplish a number of mobile device ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, ... safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP FOR ... easy to use and could be set up in a matter of minutes, or ...
(Date:12/9/2016)... Harrisburg, PA (PRWEB) , ... December 09, 2016 ... ... concussion education program through the Pennsylvania Cable Network (PCN) during the summer of ... Brain Injury Implementation Grant provided by the United States Department of Health and ...
(Date:12/8/2016)... ... 2016 , ... ZyDoc , a New York-based medical ... Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” has ... usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ natural ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Eli Lilly and Company (NYSE: LLY ... EXPEDITION3 trial at the 9 th Clinical Trials ... did not meet the primary endpoint in the EXPEDITION3 ... with mild dementia due to Alzheimer,s disease (AD), and ... the treatment of mild dementia due to AD. ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: